Arejas J. Uzgiris

leads the Center for Innovation in Diagnostics in North America for Siemens Healthineers. His scientific focus is on combining in vitro diagnostic tests, imaging modalities, and machine learning techniques for earlier diagnosis to enable more effective treatment of neurodegeneration, cancer, cardiovascular and infectious diseases. His most recent work, in collaboration with Biogen, Novartis, and Johns Hopkins University, helped to translate neurofilament light chain (NfL) testing into use for groundbreaking clinical trials in multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease.